GLP-2 analog teduglutide significantly reduces need for parenteral nutrition and stool frequency in a real-life setting

BACKGROUND: To evaluate the benefits of teduglutide in a real-life setting, we analyzed the data of 14 patients with short bowel syndrome treated with teduglutide. Additionally, we studied glucagon-like peptide 2 (GLP-2) receptor expression in samples of small intestinal and colonic tissue to provid...

Descripción completa

Detalles Bibliográficos
Autores principales: Schoeler, Marc, Klag, Thomas, Wendler, Judith, Bernhard, Simon, Adolph, Michael, Kirschniak, Andreas, Goetz, Martin, Malek, Nisar, Wehkamp, Jan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6196620/
https://www.ncbi.nlm.nih.gov/pubmed/30364471
http://dx.doi.org/10.1177/1756284818793343

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6196620/
https://www.ncbi.nlm.nih.gov/pubmed/30364471
http://dx.doi.org/10.1177/1756284818793343

Ejemplares similares